<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2022-05-17">17 May 2022</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Henrik</forename><forename type="middle">E</forename><surname>Mei</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ina</forename><surname>Wirries</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniela</forename><surname>Fr Ölich</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mikael</forename><surname>Brisslert</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Rheumatology and Inflammation Research</orgName>
								<orgName type="institution">Sahlgrenska Academy at University of Gothenburg</orgName>
								<address>
									<settlement>Gothenburg</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Claudia</forename><surname>Giesecke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joachim</forename><forename type="middle">R</forename><surname>Gr</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Bioinformatics Group</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tobias</forename><surname>Alexander</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="laboratory">Autoimmunology Group</orgName>
								<orgName type="institution">German Rheumatism Research Center Berlin</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefanie</forename><surname>Schmidt</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katarzyna</forename><surname>Luda</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anja</forename><forename type="middle">A K</forename><surname>Ühl</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Medicine I for Gastroenterology, Infectious Diseases and Rheumatology</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robby</forename><surname>Engelmann</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute of Immunology</orgName>
								<orgName type="institution">University of Rostock</orgName>
								<address>
									<settlement>Rostock</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tobias</forename><surname>Scheel</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Department of Nephrology</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="laboratory">Signal Transduction Group</orgName>
								<orgName type="institution">German Rheumatism Research Center Berlin</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><surname>Bokarewa</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Rheumatology and Inflammation Research</orgName>
								<orgName type="institution">Sahlgrenska Academy at University of Gothenburg</orgName>
								<address>
									<settlement>Gothenburg</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carsten</forename><surname>Perka</surname></persName>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Department of Orthopedics</orgName>
								<orgName type="department" key="dep2">Center for Musculoskeletal Surgery</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Radbruch</surname></persName>
							<affiliation key="aff13">
								<orgName type="laboratory">Cell Biology Group</orgName>
								<orgName type="institution">German Rheumatism Research Center Berlin</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><forename type="middle">D</forename><surname>Örner</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charit é University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="laboratory">Cell Memory Group</orgName>
								<orgName type="institution">German Rheumatism Research Center Berlin</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">Leibniz Institute</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">Leibniz Institute</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="institution">Leibniz Institute</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="institution">Leibniz Institute</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="institution" key="instit1">Charité University Medicine</orgName>
								<orgName type="institution" key="instit2">University of Gothenburg and Rostock University</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2022-05-17">17 May 2022</date>
						</imprint>
					</monogr>
					<idno type="MD5">F6A23EB252A9C653E734170BEE0CBB2E</idno>
					<idno type="DOI">10.1182/blood-2014-</idno>
					<note type="submission">Submitted February 7, 2014; accepted December 2, 2014. Prepublished online as Blood First Edition paper, January 8, 2015;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:31+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Healthy human BM is enriched for PC lacking CD19 that express a prosurvival and distinctly mature phenotype.</s></p><p><s>• CD19 2 PC resist mobilization into blood during immune responses after vaccination as well as B-cell depletion with rituximab.</s></p><p><s>Specific serum antibodies mediating humoral immunity and autoimmunity are provided by mature plasma cells (PC) residing in the bone marrow (BM), yet their dynamics and composition are largely unclear.</s><s>We here characterize distinct subsets of human PC differing by CD19 expression.</s><s>Unlike CD19 1 PC, CD19 2 PC were restricted to BM, expressed predominantly IgG, and they carried a prosurvival, distinctly mature phenotype, that is, HLA-DR low Ki-67 2 CD95 low CD28 1 CD56 1/2 , with increased BCL2 and they resisted their mobilization from the BM after systemic vaccination.</s><s>Fewer mutations within immunoglobulin V H rearrangements of CD19 2 BMPC may indicate their differentiation in early life.</s><s>Their resistance to in vivo B-cell depletion, that is, their independency from supply with new plasmablasts, is consistent with long-term stability of this PC subset in the BM.</s><s>Moreover, CD19 2 PC were detectable in chronically inflamed tissues and secreted autoantibodies.</s><s>We propose a multilayer model of PC memory in which CD19 1 and CD19 2 PC represent dynamic and static components, respectively, permitting both adaptation and stability of humoral immune protection.</s><s>(Blood.</s><s>2015;125(11):1739-1748)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head><p><s>Detailed information is provided in the online supplement.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Blood and tissue cells</head><p><s>Single leukocyte or mononuclear cell suspensions were prepared from BM, tonsil, spleen, kidney, and blood according to standard protocols.</s><s>Some blood samples were analyzed after vaccination against tetanus/diphtheria</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Protective and autoreactive serum antibodies (sAb) are essential for immune protection and contribute to autoimmunity, respectively.</s><s>Ab are secreted by terminally differentiated B lymphocytes, termed plasma cells (PC), and their immediate precursors, the plasmablasts (PB).</s><s>Although PB generated in acute B-cell responses transiently contribute to sAb, the stability of specific sAb through extended periods may reflect long-term persistence of functional PC.</s><s>2]<ref type="bibr" target="#b2">[3]</ref> Possibly as a result of successful residence in a survival niche, PC express the antiapoptotic transcription factor Bcl-2 <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref> as a molecular trait of long-term PC survival.</s><s>In humans, long-term sAb titer half-lives differ by specificity #100-fold, <ref type="bibr" target="#b5">6</ref> possibly reflecting differential survival patterns among PC subsets that maintain these titers.</s></p><p><s>We here characterize human PC lacking CD19 expression.</s><s>These were strongly enriched in the BM and they expressed an antiapoptotic and distinctly mature phenotype, sharing similarities with murine long-lived PC.</s></p><p><s>On mature B cells, CD19 is a coreceptor of the B-cell receptor and regulates its signaling. <ref type="bibr" target="#b6">7</ref></s><s>Its expression appears as solely regulated by PAX5. <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9</ref></s><s>During PC differentiation, PAX5 is downregulated, <ref type="bibr" target="#b9">10</ref> whereas CD19 is apparently lost only from a subset of PC.</s><s>Lack of CD19 has been described as a hallmark of malignant PC. <ref type="bibr" target="#b10">11</ref> However, CD19 1 and CD19 2 , including CD19 2 CD56 1 PC have been reported in healthy BM, <ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref> but their potential significance has remained unexplored.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Single-cell sorting and reverse transcriptase-polymerase chain reaction</head><p><s>Individual PB and PC were sorted into 96 well plates using a FacsAria (BD Biosciences).</s><s>V H DJ H C genes were amplified, sequenced, and analyzed using Chromas 2.33 Sequence Viewer (Chromas Technelysium, Helensvale, Australia), the BLAST database of the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov), and JOINSOLVER (http:// joinsolver.niaid.nih.gov/)</s><s>according to previously published protocols. <ref type="bibr" target="#b17">18</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistology</head><p><s>Cryosections of synovial biopsies were stained for CD138 and CD19.</s><s>Nuclei were counterstained with DAPI.</s><s>Images were acquired using a fluorescence microscope (AxioImager Z1) equipped with a charge-coupled device camera (AxioCam MRm) and processed with Axiovision software (Carl Zeiss MicroImaging, Thornwood, NY).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>FlowJo (TreeStar, Ashland, OR) version 7.2.5 and GraphPad Prism 6 (GraphPad Software, San Diego, CA) were used to analyze data.</s><s>Statistical significance was calculated using the Mann-Whitney U test for comparisons between patient groups at different time points.</s><s>The Wilcoxon test was used to compare paired observations (both 95% confidence interval, 2-tailed).</s><s>Spearman's rank correlation analysis (2-tailed, 95% confidence interval) was performed.</s><s>Levene's test was used in SPSS v19 (IBM, Ehningen, Germany) to compare variances.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>The human BM is enriched for CD19 2 PC and represents their major storage site First, the expression of CD19 by PC in peripheral blood, BM, tonsil, and spleen was analyzed by flow cytometry, and frequencies as well as total numbers of CD19 1 and CD19 2 PC residing in these tissues were determined <ref type="bibr" target="#b19">20</ref> (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>PC (including PB) were identified by high expression of CD38, CD138, or CD27, or combinations thereof, expressed CD20 low/2 and showed characteristically increased forward scatter and sideward scatter signals compared with other lymphocytes (supplemental Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>Their PC identity was confirmed by the expression of cytoplasmic (cyt) immunoglobulin <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b16">17</ref> (Figure <ref type="figure" target="#fig_2">2A</ref>) and for both, CD19 2 and CD19 1 BMPC, by spontaneous secretion of antibodies as detected by Elispot (supplemental Figure <ref type="figure" target="#fig_2">2</ref>).</s><s>CD19 2 PC were detected as the numerically smaller PC population in the BM and at significantly lower frequencies in spleen, tonsil, and blood (Figure <ref type="figure" target="#fig_1">1A</ref>).</s><s>On average, 33% (median, range 9% to 56%) of PC in the BM did not express CD19, compared with 2% in tonsils (0% to 25%), 8% in spleens (3% to 16%), and 5% in peripheral blood (0% to 11%, Figure <ref type="figure" target="#fig_1">1B</ref>, P , .001),</s><s>respectively.</s><s>Concurrently, the BM contained the majority of CD19 2 PC (median 2.0 3 10 8 cells) among the tissues analyzed, more than the blood, spleen, and tonsils altogether (0.5 3 10 8 cells) (Figure <ref type="figure" target="#fig_1">1C</ref>).</s><s>Frequencies of CD19 2 PC varied but were not significantly different between anatomic BM sites analyzed, that is, sternum (median 20%), femoral head (33%), and iliac crest (28%, Figure <ref type="figure" target="#fig_1">1D</ref>).</s></p><p><s>CD19 2 BMPC are enriched for IgG expression and carry fewer mutations in their V H DJ H gene rearrangements compared with CD19 1 BMPC BMPC have been suggested as the major source of IgG in rodents. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref></s><s>We therefore analyzed the expression of the antibody isotype produced by individual human BMPC so as to estimate the contribution of CD19 1 vs CD19 2 BMPC to systemic IgG production (Figure <ref type="figure" target="#fig_2">2A</ref>).</s><s>In 11 BM samples analyzed, 71% of CD19 2 PC expressed IgG (median, range 52% to 86%), followed by IgA (22%, 5% to 41%) and IgM (7%, 2% to 11%).</s><s>Within CD19 1 BMPC, IgA was most abundantly expressed (53% of PC, 36% to 70%), followed by IgG (41%, 27% to 61%) and IgM (3%, 1% to 8%) (Figure <ref type="figure" target="#fig_2">2B</ref>).</s><s>Isotype-specific Elispot and analyses of IgV H DJ H C gene rearrangements amplified from individual BMPC confirmed these results (supplemental Figure <ref type="figure" target="#fig_2">2A-B</ref>).</s><s>To gain insight into the composition of BMPC subsets and the differentiation of individual CD19 1 and CD19 2 BMPC, the same IgV H DJ H C sequences were used to assess the use of V H and J H gene family members, the acquisition of somatic mutations within IgV H gene rearrangements, and CDR3 region lengths.</s><s>CD19 1 and CD19 2 BMPC used V H and J H gene family members at comparable frequencies, irrespective of whether total or IgG 1 BMPC were analyzed (Figure <ref type="figure" target="#fig_2">2C</ref>), indicating similar selection of the B cells that differentiated into CD19 1 and CD19 2 BMPC, respectively.</s><s>A total of 95% of the sequences analyzed represented unique V H DJ H gene rearrangements, reflecting a polyclonal V H and J H gene repertoire.</s><s>Clonally related BMPC were uncommon.</s><s>A total of 2 clonally related sequence pairs were detected in 1 of 3 donors, with 1 clone shared between CD19 2 and CD19 1 BMPC (supplemental Table <ref type="table">I</ref>).</s></p><p><s>Although mutation numbers and frequencies did not differ between CD19 1 and CD19 2 BMPC of the IgA isotype, CD19 2 IgG 1 PC showed markedly lower total mutations (median 18 vs 24 mutations per V H sequence, P 5 .0022)</s><s>and mutation frequencies (7.7% vs 10.5%, P 5 .0007)</s><s>but not significantly longer CDR3 sequences (median 45 base pair vs 42 base pair, P 5 .1583)</s><s>compared with CD19 1 IgG 1 BMPC (Figure <ref type="figure" target="#fig_2">2D</ref>).</s><s>TT-specific IgG 1 PB circulating 1 week after systemic vaccination are thought to migrate to the BM and represent potential precursors of BMPC. <ref type="bibr" target="#b22">23</ref></s><s>ndeed, TT-specific cells were found among both BMPC subsets in all 4 donors tested at frequencies between 0.27‰ and 1.56‰ (Figure <ref type="figure" target="#fig_2">2E</ref>).</s><s>However, only CD19 1 IgG 1 BMPC showed similar mutation frequencies compared with blood TT-specific PB (9.7% vs 10.5%, P 5 .1563),</s><s>whereas IgG 1 CD19 2 BMPC showed a significantly lower mutation frequency (7.7%, P 5 .0005;</s><s>Mann-Whitney U test, Figure <ref type="figure" target="#fig_2">2D</ref>).</s><s>This is consistent with our hypothesis that in adults, TT-specific PB of the blood could represent precursors of CD19 1 BMPC, but not precursors of CD19 2 BMPC.</s></p><p><s>CD19 2 BMPC express a prosurvival and uniquely advanced differentiated PC phenotype Global gene expression profiles of FACS-sorted CD19 1 and CD19 2 PC (supplemental Figure <ref type="figure" target="#fig_5">4</ref>) showed significantly different signals in 859 Affymetrix probe sets corresponding to 689 differentially expressed genes (Figure <ref type="figure" target="#fig_4">3A</ref>; supplemental Table IIIA).</s><s>Among these, signal intensities for molecules otherwise unrelated to B cells, CD28 and CD56, were significantly upregulated in CD19 2 BMPC, which was confirmed by FACS analyses.</s><s>Vice versa, HLA-DR, previously described as a marker of PB <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b22">23</ref> and the death receptor CD95, <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25</ref> were downregulated in CD19 2 BMPC (both P , .001) (Figure <ref type="figure" target="#fig_4">3B</ref>).</s><s>The low expression of CD95 by CD19 2 BMPC was accompanied by lower Affymetrix signal intensities of proapoptotic mediators such as TNFRSF10B <ref type="bibr" target="#b25">26</ref> and BID, the apoptosis effector caspases 3 and 8, whereas higher signals were found for BCL2L11 and the antiapoptotic factor BCL2 27 in CD19 2 BMPC compared with CD19 1 BMPC (Figure <ref type="figure" target="#fig_4">3C</ref>; supplemental Table IIIB).</s><s>Receptors for the PC survival factors IL-6, CXCL12, BAFF, and APRIL, as well as a critical mediator of murine PC survival, Mcl-1, <ref type="bibr" target="#b27">28</ref> were expressed at comparable levels in human CD19 1 and CD19 2 BMPC (supplemental Table IIIB-C).</s><s>To test whether the differences found in apoptosis regulators translate into a survival advantage for CD19 2 or CD19 1 BMPC, we analyzed the survival of FACS-sorted CD19 1 and CD19 2 BMPC in vitro.</s><s>Most PC died within 24 hours after sorting, yet consistently higher frequencies were recovered for viable CD19 2 compared with CD19 1 BMPC after 3 to 9 days of culture.</s><s>For example, 11.1% vs 6.1%, 5.7% vs 2.4%, and 2.7% vs 1.8%, respectively, were recovered of cultured CD19 2 vs CD19 1 BMPC after 8 to 9 days (3 experiments).</s><s>Thus the vast majority of CD19 2 BMPC expressed the phenotype of uniquely differentiated PC, that is, CD38 high CD138 1 CD19 2 CD28 1 HLA-DR low CD56 1/2 CD95 low with increased BCL2 and enhanced survival in vitro, suggesting their enhanced survival capacity in vivo and their involvement in long-term sAb maintenance.</s><s>Next we studied the proliferation and survival of CD19 1 and CD19 2 BMPC by analyzing Ki-67 expression and the impact of in vivo B-cell depletion by anti-CD20 treatment leading to suppression of systemic PB generation.</s></p><p><s>Different from peripheral blood PB/PC, Ki-67 1 cells were infrequent among BMPC, that is, more than 95% of PC in the BM represented resting cells.</s><s>However, CD19 1 BMPC contained significantly more Ki-67 1 cells compared with CD19 2 BMPC.</s><s>Frequencies of Ki-67 1 cells among CD19 2 BMPC were 0.9% (median, compared with 0.0% control stained cells), and 3.6% within CD19 1 BMPC (compared with 0.5%, respectively, P , .05)</s><s>(Figure <ref type="figure" target="#fig_5">4A</ref>).</s></p><p><s>Treatment with RTX resulting in CD20 1 B-cell depletion resulted in a different impact on CD19 1 vs CD19 2 BMPC in vivo.</s><s>After such treatment, CD19 1 B cells were absent from peripheral blood, <ref type="bibr" target="#b28">29</ref> and numbers of CD19 1 but not CD19 2 BMPC were significantly reduced (23 patients) when CD19 1 and CD19 2 BMPC were analyzed simultaneously from BM samples taken before and 1 to 3 months after therapy, respectively.</s><s>Although we noted some heterogeneity of BMPC subsets across individual donors, the overall   BMPC from 3 individuals were subjected to nested single-cell reverse transcriptase-polymerase chain reaction for amplification of V H DJ H C gene rearrangements. <ref type="bibr" target="#b17">18</ref></s><s>A total of 82 sequences from CD19 1 PC and 72 sequences from CD19 2 BMPC were analyzed: 33 CD19 1 IgG 1 , 44 CD19 2 IgG 1 , 46 CD19 1 IgA 1 , and 24 CD19 2 IgA 1 sequences (and 7 IgM sequences, not separately shown).</s><s>Sequences were analyzed for immunoglobulin isotype (supplemental Figure <ref type="figure" target="#fig_2">2B</ref>) for V H and J H family use.</s><s>Distributions were compared by x 2 test; respective P values are indicated (C), for absolute numbers and frequencies of somatic mutations per V H sequence, and for CDR3 length and mutations located within RGYW/WRCY hotspot motifs (D).</s><s>Data from 65 tetanus toxoid (TT)-specific PB <ref type="bibr" target="#b17">18</ref>  data indicate that CD19 2 BMPC appear to be more resistant to peripheral B-cell depletion by RTX, that is, they do not depend, or they depend less, on the supply of new PB (Figure <ref type="figure" target="#fig_5">4B</ref>).</s><s>Thus CD19 1 and CD19 2 BMPC showed different cell proliferation and population persistence characteristics in independent in vivo and ex vivo analyses, identifying CD19 1 BMPC as the more dynamic and CD19 2 BMPC the rather static PC population, respectively.</s><s>Although these data capture the dynamics of BMPC subsets during steady state, it remained unclear whether or not CD19 2 BMPC are induced during or mobilized into blood after systemic immune responses.</s></p><p><s>CD19 1 , but not CD19 2 (HLA-DR low ) PC appear in the blood after vaccination One week after TetDiph vaccination, mature HLA-DR low PC emerge in human blood simultaneously with proliferating and migratory, antigen-specific PB. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b22">23</ref> We subsequently analyzed CD19 and CD56 expression by these cells to identify whether circulating CD19 2 CD56 1/2 HLA-DR high PB were generated in such an immune response and/or whether mature CD19 2 CD56 1/2 HLA-DR low PC were mobilized into the blood after vaccination. <ref type="bibr" target="#b22">23</ref></s><s>In accordance with previous studies, <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b22">23</ref> intramuscular TetDiph vaccination induced an increase of IgG 1 HLA-DR high PB in peripheral blood 1 week after vaccination, including TT-specific PB.</s><s>Throughout the course of the immune response, few if any TT-specific PB expressed the CD19-negative phenotype, as did total HLA-DR high expressing PB and HLA-DR low PC (Figure <ref type="figure" target="#fig_6">5A</ref>).</s><s>Similar results were obtained after vaccination against H1N1 with Pandemrix, which led to a substantial induction of peripheral blood PB/PC 1 week after vaccination (30 290 to 95 480 PB/PC/mL, 4 donors) (Figure <ref type="figure" target="#fig_6">5B</ref>).</s><s>Notably, CD56 1 PB or PC were not detectable in the blood during steady state (11 donors) and were also absent from the blood 1 week after vaccination with TetDiph or Pandemrix vaccine (5 and 4 donors, respectively) (Figure <ref type="figure" target="#fig_6">5C</ref>), confirming the absence from blood of CD56 1 PC that are routinely detectable in BM, especially within the CD19 2 BMPC subset.</s></p><p><s>Taken together, CD19 2 PC including CD56 1 PC were restricted to BM residence also during the adaptation of the BMPC pool after vaccination in adulthood.</s><s>Thus downregulation of CD19 and upregulation of CD56 by PC apparently occurs in situ after their immigration into the BM, suggesting ongoing differentiation of PC within the BM.</s></p><p><s>CD19 2 PC accumulate in inflamed tissue and are affected by rATG and bortezomib treatment Whereas CD19 2 PC were apparently restricted to the BM in healthy individuals, CD19 2 PC were also detectable in inflamed tissues, that is, synovial biopsies from patients with rheumatoid arthritis (2 samples) as well as in kidneys explanted after chronic humoral graft rejection (Figure <ref type="figure">6A-B</ref>).</s><s>In a BM sample from one systemic lupus erythematosus (SLE) patient, dsDNA-specific IgG-secreting cells were detectable among both, CD19 1 and CD19 2 BMPC (Figure <ref type="figure">6C</ref>), at frequencies of 0.8 and 1.3 PC per 10 000 total CD19 1 and CD19 2 BMPC, respectively.</s></p><p><s>Moreover, we studied whether CD19 1 and CD19 2 PC were affected in vitro and in vivo by therapeutics considered to target PC. <ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31</ref></s><s>D19 1 and CD19 2 BMPC were similarly bound by fluorescently labeled rATG whereas RTX that was used as a control bound to ,10% of CD19 1 BMPC but not to CD19 2 BMPC (supplemental Figure <ref type="figure" target="#fig_4">3A</ref>).</s><s>In vitro, the addition of the proteasome inhibitor bortezomib, but not RTX, resulted in reductions of CD19 1 BMPC by 76% and of CD19 2 PC by 64%, respectively, within 3 days from total BM cell cultures (mean values, 3 experiments) when compared with control cultures (supplemental Figure <ref type="figure" target="#fig_4">3B</ref>).</s><s>The BM from 2 individual patients with antibody-mediated diseases treated with either bortezomib or rATG contained very low frequencies of total PC, which comprised both CD19 1 and CD19 2 BMPC (supplemental Figure <ref type="figure" target="#fig_4">3C-D</ref>).</s><s>Thus both drugs appear principally capable to impact on BMPC (or their supportive environment) in vivo.</s><s>However, the effect of both drugs on BMPC needs to be addressed more systematically to verify this finding.</s></p><p><s>These results demonstrate the presence of otherwise BM-restricted CD19 2 PC at sites of inflammation in antibody-mediated diseases and they provide direct evidence for their numerical reduction after treatment with rATG and bortezomib but not RTX in humans.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Specific IgG Ab are an important line of human immune defense.</s><s>The dynamics especially of the human PC pool is still minimally understood, whereas medical interventions to improve immune protection and to treat antibody-mediated diseases demand better insight into PC homeostasis.</s></p><p><s>Following their generation, differentiating PB migrate to and may become resident in the BM <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b31">32</ref> and in secondary lymphoid tissues.</s><s>PC of the BM generate most sAb. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref></s><s>Their survival depends on factors provided by cells and matrix components constituting a putative survival niche. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b32">33</ref></s><s>A fraction of nondividing antigenspecific IgG 1 PC in the BM has been described as particularly long lived. <ref type="bibr" target="#b1">2</ref> These are strongly implicated in the long-term maintenance of specific sAb levels (humoral memory) that is reflected in humans by the observed stability of specific sAb titers, <ref type="bibr" target="#b5">6</ref> including sAb specific for a long-term eradicated pathogen, smallpox. <ref type="bibr" target="#b33">34</ref></s><s>Long-lived PC have been coined memory PC, <ref type="bibr" target="#b4">5</ref> and they were shown to contribute to autoreactive sAb production, to resist cytostatic treatment, and to be maintained in inflamed kidneys in a mouse model of SLE. <ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b35">36</ref></s><s>uman CD19 2 BMPC described in this study reside in the BM, and, in immunopathology, within inflamed tissue, and they show little if any signs of proliferation, thus sharing key features of mouse longlived PC. <ref type="bibr" target="#b36">37</ref> Like murine long-lived Blimp-1 high BMPC, notably showing reduced CD19 and HLA-DR expression, <ref type="bibr" target="#b36">37</ref> human BMPC appear to acquire their characteristic CD19 2 phenotype in situ.</s><s>The nature of this developmental process remains to be delineated.</s><s>In support of a survival advantage of human CD19 2 BMPC, they showed mostly antiapoptotic characteristics when isolated ex vivo and enhanced spontaneous survival in vitro.</s></p><p><s>CD19 2 BMPC further express indicators of advanced PC maturity such as CD28 <ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b38">39</ref> and CD56.</s><s>In mice, CD28 is expressed by PC after downregulation of PAX5, <ref type="bibr" target="#b38">39</ref> and CD28 contributes to the regulation of the mature BMPC <ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b40">41</ref> although its exact role needs to be delineated. <ref type="bibr" target="#b41">42</ref></s><s>mportantly, neoplastic CD28 1 PC are able to modulate their own microenvironment, <ref type="bibr" target="#b42">43</ref> and normal PC can induce production of the PC survival factor IL-6 by stromal cells, <ref type="bibr" target="#b43">44</ref> that is, cells to which PC stably attach in the BM. <ref type="bibr" target="#b44">45</ref></s><s>The ability of a subset of PC to shape their own niche could contribute to their stability even when the niche is transiently disrupted.</s><s>Indeed, some PC survive the depletion of PCsupporting basophils, <ref type="bibr" target="#b45">46</ref> eosinophils, <ref type="bibr" target="#b46">47</ref> and megakaryocytes. <ref type="bibr" target="#b47">48</ref></s><s>Moreover, CD56 may have a role in the stable positioning of CD56 1 PC in the BM, via homotypic interaction with CD56 1 osteoblasts <ref type="bibr" target="#b48">49,</ref><ref type="bibr" target="#b49">50</ref> and/or possibly mesenchymal stem cells. <ref type="bibr" target="#b50">51,</ref><ref type="bibr" target="#b52">52</ref></s><s>The association of higher CD56 expression by PC tumors with lower PC numbers in the blood and less BM infiltration or osteolysis <ref type="bibr" target="#b53">53,</ref><ref type="bibr" target="#b54">54</ref> supports that CD56 is indeed involved in the in situ arrest of PC.</s></p><p><s>CD19 2 BMPC also downregulated HLA-DR and appear to be protected from mobilization during immune responses, potentially contributing to the robustness and stability of this PC subset in the BM.</s><s>In contrast, CD19 1 BMPC could represent a source of HLA-DR low PC that appear in blood at day 7 after systemic vaccination. <ref type="bibr" target="#b22">23</ref></s><s>As vaccine-induced antigen-specific PB and CD19 1 BMPC share phenotypical and molecular V H sequence properties, CD19 1 BMPC candidate as the primary PC subset to accommodate new PB in the adult BM.</s></p><p><s>In contrast to CD19 2 BMPC, CD19 1 BMPC expressed a less mature phenotype (CD28 -HLA-DR high/low CD95 1 ) consistent with susceptibility to apoptosis, and they contained somewhat more proliferating cells during steady-state and showed partial dependency on the presence of peripheral B cells, suggesting a more dynamic nature and possibly adaptation capacity of the CD19 1 BMPC subset.</s><s>Whether such BMPC proliferation plays a role for the maintenance of serum IgG in addition to regulation of immunoglobulin secretion by PC <ref type="bibr" target="#b55">55</ref> and PC survival remains to be addressed.</s><s>Despite considerable heterogeneity in their response to B-cell depletion, CD19 2 BMPC did not significantly depend on the presence of peripheral B cells, thus comparing to PC surviving B-cell depletion in mice, <ref type="bibr" target="#b56">56</ref> in inflamed synovia <ref type="bibr" target="#b57">57</ref> and PC-producing protective and certain autoreactive sAb. <ref type="bibr" target="#b58">58,</ref><ref type="bibr" target="#b59">59</ref></s><s>CD20 expression by both BMPC subsets was similarly weak or absent as measured by a commercial antibody (supplemental Figure <ref type="figure" target="#fig_1">1E</ref>).</s><s>However, we identified weak binding of RTX to CD19 1 BMPC, but RTX did not  BMPC subsets exhibit different ex vivo proliferation and in vivo persistence.</s><s>(A) CD19 1 and CD19 2 BMPC and peripheral blood PB/PC were analyzed for the expression of Ki-67 after cell fixation with formaldehyde and permeabilization with saponin.</s><s>Frequencies of Ki-67 1 cells are shown and were compared between blood PB/PC (6 samples, steady state) and BMPC subsets (Mann-Whitney U test; ***P , .001) and among pairs of BM CD19 1 and CD19 2 PC (Wilcoxon test; *P , .05).</s><s>Filled circles, Ki-67 staining (10 samples); open circles, control staining (available for 7 samples).</s><s>Both BMPC subsets show frequencies of Ki-67 1 cells significantly exceeding frequencies of isotype control stained cells (Mann-Whitney U test; both P , .01).</s><s>Median values are indicated.</s><s>(B) BM samples of 23 patients with rheumatoid arthritis treated with 2 3 1 g RTX (a chimeric anti-CD20 antibody) were analyzed for the presence of CD138 1 CD19 1 and CD138 1 CD19 2 PC twice, once before, and once again 1 to 3 months after treatment.</s><s>PC were detected by flow cytometry, and their numbers were extrapolated according to Trepel <ref type="bibr" target="#b19">20</ref> and were analyzed using the Wilcoxon test; *P , .05.</s><s>Lines between data points indicate the trend shown by individual patients.</s><s>Mean numbers of 3.10 3 10 8 (standard deviation [SD], 1.76 3 10 8 ) CD19 1 and 1.36 3 10 8 (SD, 0.85 3 10 8 ) CD19 2 BMPC compare with 2.24 3 10 8 (SD, 1.69 3 10 8 ) CD19 1 and 1.06 3 10 8 (SD, 0.93 3 10 8 ) CD19 2 BMPC after therapy, respectively.</s><s>deplete those in vitro (supplemental Figure <ref type="figure" target="#fig_4">3B</ref>), so that differential effects of the in vivo RTX treatment appear as unrelated to potentially residual CD20 expression by PC.</s><s>Numbers of CD19 2 BMPC showed lower variance across donors than CD19 1 BMPC, (36 samples, Levene's test, P 5 .005),</s><s>possibly reflecting that their numbers are a conserved biological characteristic.</s><s>In conclusion, CD19 2 BMPC appear as a more durable memory PC differentiation stage distinct from CD19 1 PC.</s><s>Our data are consistent with a model in which CD19 2 BMPC represent a rather static population of presumably long-lived PC with a molecular survival imprint, whereas CD19 1 BMPC comprise a more dynamic subset whose survival may depend on factors that do not induce increased levels of BCL2.</s><s>As Bcl-2 alone is not able to prevent PC from dying, <ref type="bibr" target="#b3">4</ref> it may rather represent an indicator of the long-term residence of CD19 2 BMPC in a PC-supporting BM habitat.</s></p><p><s>Thus we propose that humoral immunity relies on distinct subsets of PC with complementary functions and different dynamics.</s><s>This model can explain the robustness of sAb titers, including adaptation of the memory PC pool after immune responses.</s><s>Moreover, the differing half lives of specific serum IgG titers 6 on the background of limited numbers of total PC in the BM might be related to distribution of antigen-specific PC into CD19 1 and CD19 2 PC pools, respectively.</s></p><p><s>The in situ differentiation of CD19 2 BMPC suggests a sequential differentiation process in which circulating PB immigrate the BM and fuel the CD19 1 BMPC population, and some CD19 1 BMPC may further mature into CD19 2 BMPC.</s><s>Although the determinants of this putative differentiation pathway remain unknown, the enrichment of IgG expression and the lower mutation frequency of V H gene rearrangements of CD19 2 BMPC compared with CD19 1 BMPC imply that such differentiation does not occur in adults regularly, because that would reflect the selection of PC with lower somatic mutations into the CD19 2 PC pool, which appears unlikely.</s><s>A different scenario involves differentiation of CD19 1 into CD19 2 PBMC during childhood or early life, and thereafter, once the pool of CD19 2 BMPC is established, the differentiation of CD19 1 into new CD19 2 PC is either inhibited or CD19 2 BMPC formed later in life do not successfully establish and they die.</s><s>The lower mutation frequency observed in CD19 2 BMPC may reflect their differentiation from (memory) B cells that experienced limited antigenic restimulation, such as in early life. 60,61</s><s>CD19 2 BMPC observed here may reflect descendants of, for example, secondary or tertiary immune responses that persisted since their generation until the time point of sampling, because blood PB induced in primary immune responses showed apparently less somatic hypermutation 62 compared with CD19 2 IgG 1 BMPC, whereas those resulting from TetDiph booster vaccination in adults carried more somatic hypermutations.</s><s>In contrast, CD19 1 BMPC in the same samples might stem from more recent recall responses, and may have differentiated from memory B cells that underwent more cycles of affinity maturation, therefore showing a higher degree of somatic hypermutation.</s><s>In that regard, according to national vaccination guidelines (www.rki.de),</s><s>TetDiph vaccinations in adulthood (18 to 60 years) represent the seventh to 11th intentional immunization with the same antigen.</s></p><p><s>This overall scenario complies with the selection of PC for higher antigen affinity and higher mutational frequencies within IgV H gene rearrangements compared with their memory B-cell or germinalcenter counterparts. <ref type="bibr" target="#b63">63,</ref><ref type="bibr" target="#b64">64</ref></s><s>Interestingly, BM samples from infants aged 5 to 7 months uniformly lacked CD19 2 BMPC but contained CD19 1 BMPC (supplemental Figure <ref type="figure" target="#fig_2">2C</ref>).</s><s>This indicates that CD19 1 PC are the first to appear in BM, and could be subject to sequential differentiation and selection of CD19 1 into CD19 2 BMPC during childhood or adolescence.</s></p><p><s>Whereas the lower mutational frequency of CD19 2 BMPC could also indicate limitations in T-cell help, the presence of PC specific for a T-dependent antigen (tetanus) as well as frequent targeting of mutations into mutational hot spots argues against the view that CD19 2 BMPC were formed during T-cell independent responses.</s></p><p><s>Secretion of autoreactive IgG from CD19 2 (but also CD19 1 ) BMPC and their detection in inflamed tissues implicate a participation of CD19 2 PC in the immunopathology of antibody-mediated diseases.</s><s>In this regard, we provide initial data from single patients indicating that both CD19 2 and CD19 1 BMPC were numerically reduced after treatment with the proteasome inhibitor bortezomib as well as rATG used in immunoablation protocols.</s><s>Direct targeting of PC by rATG and bortezomib appears likely, because bortezomib is effective against PC tumors by inducing apoptosis, and rATG directly binds to BMPC. <ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b65">65,</ref><ref type="bibr" target="#b66">66</ref></s><s>In vivo, these treatments can additionally impact on PC numbers indirectly by affecting their environment.</s><s>As our data represent single cases, the results require validation in larger cohorts.</s><s>Anti-CD19 therapies in development for treatment of patients with lymphoma and also autoimmunity <ref type="bibr" target="#b67">67,</ref><ref type="bibr" target="#b68">68</ref> are unlikely to target CD19 2 PC directly.</s></p><p><s>In multiple myeloma patients, many PC tumors share the phenotype we describe for normal CD19 2 BMPC, including expression of CD56, <ref type="bibr" target="#b69">69</ref> and CD28, <ref type="bibr" target="#b15">16</ref> and enhanced CD200 signals (supplemental Table <ref type="table">IIID</ref>). <ref type="bibr" target="#b70">70,</ref><ref type="bibr" target="#b71">71</ref></s><s>However, CD117 is rated absent in the transcriptional profiles of CD19 1 and CD19 2 BMPC; CD19 2 BMPC Figure <ref type="figure">6</ref>.</s><s>CD19 2 PC are detectable at sites of chronic inflammation and can secrete autoantibodies.</s><s>(A) Synovial biopsies from 2 patients with rheumatoid arthritis were analyzed by immunofluorescence histology for the presence of CD138 1 DAPI 1 CD19 1 and CD138 1 DAPI 1 CD19 2 PC (1 out of 2 cases is shown).</s><s>Upper and lower panels originate from the identical staining and section.</s><s>(B) Kidney tissue from 2 patients after humoral rejection was digested by collagenase V, and mononuclear cells were analyzed by flow cytometry for the presence of CD19 1 and CD19 2 PC.</s><s>PC were identified using high expression of CD38 within a wide lymphocyte gate and electronic depletion of CD3 1 cells, CD14 1 cells, and dead cells.</s><s>In 1 of the 2 cases, CD19 expression by PC was controlled using an isotype-matched control antibody, and the PC identity was confirmed by the detection of intracellular immunoglobulin (cyt k and l Ab light chains).</s><s>Numbers denote mean fluorescence intensities.</s><s>(C) CD19 1 and CD19 2 BMPC from 1 SLE patient (serum anti-dsDNA antibodies, 84 U/mL) were isolated and subjected to an Elispot assay detecting dsDNA-specific IgG-secreting cells among 24 000 CD19 1 BMPC/well and 27 000 CD19 2 BMPC/well.</s><s>Representative wells (from 14 dsDNA-coated replicate wells and 7 bovine serum albumin-coated replicate wells per PC subset to determine assay background) and assay controls are shown.</s><s>After background subtraction, frequencies of dsDNAspecific PC were 0.8 and 1.3 PC per 10 000 total CD19 1 and CD19 2 BMPC, respectively.</s></p><p><s>were polyclonal and detectable in every BM sample analyzed in this study, confirming that they were not malignant PC.</s></p><p><s>The current study improves our understanding of regulation of humoral memory at the level of PC and their subsets, and it has implications for the development of vaccines and treatment of systemic autoimmunity.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>CD19 1</head><label>1</label><figDesc><div><p><s>and CD19 2 BMPC exhibit different stability in vivo</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure1.</s><s>The human BM is the major site of PCs lacking expression of CD19.</s><s>(A) CD19 expression by PB/PC (black histograms) was analyzed by flow cytometry in peripheral blood, tonsil, lymph node (LN), BM, and spleen samples (supplemental Figure1).</s><s>CD19 expression by total lymphocytes (dashed lines) and isotype control-stained PC (shaded) are shown for comparison in representative histograms.</s><s>Horizontal bars indicate gates used to determine frequencies of PC lacking CD19.</s><s>Frequencies of CD19 2 PC among total PC were determined (B, median values are indicated from 21 blood samples, 6 spleen samples, 1 LN/7 tonsil samples, and 34 femoral head BM samples), and numbers of CD19 2 and CD19 1 PC per organ were extrapolated for 21 blood samples, 6 spleen samples, 1 LN/7 tonsil samples, and 25 femoral head BM based on<ref type="bibr" target="#b19">20</ref> (C, median values and interquartile range shown).</s><s>Significance levels (***P , .001) obtained from Mann-Whitney U tests are shown for comparisons between BM data and other tissues.</s><s>The grey data point in (B) indicates a parotid LN. (D) Percentages of PC lacking CD19 expression were analyzed in BM samples from iliac crest (36 samples), femoral head (34 samples), and sternum (9 samples).</s><s>Kruskal-Wallis testing was used for statistical analysis.</s><s>Consistent frequencies of CD19 2 PC were determined using various anti-CD19 clones (supplemental Figure1F).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. CD19 2 BMPC express IgG with moderately mutated V H gene rearrangements and secrete antibodies commonly found in blood serum.</s><s>(A) BMPC were analyzed for expression of CD19 and cyt IgG, IgM, and IgA.</s><s>Summarized results from 11 donors are shown in (B) and were compared using the Mann-Whitney U test, ***P , .001.</s><s>Median values are indicated.</s><s>(C-D) Individual fluorescence-activated cell sorter (FACS)-sorted CD19 1 and CD192BMPC from 3 individuals were subjected to nested single-cell reverse transcriptase-polymerase chain reaction for amplification of V H DJ H C gene rearrangements.<ref type="bibr" target="#b17">18</ref></s><s>A total of 82 sequences from CD19 1 PC and 72 sequences from CD19 2 BMPC were analyzed: 33 CD19 1 IgG 1 , 44 CD19 2 IgG 1 , 46 CD19 1 IgA 1 , and 24 CD19 2 IgA 1 sequences (and 7 IgM sequences, not separately shown).</s><s>Sequences were analyzed for immunoglobulin isotype (supplemental Figure2B) for V H and J H family use.</s><s>Distributions were compared by x 2 test; respective P values are indicated (C), for absolute numbers and frequencies of somatic mutations per V H sequence, and for CDR3 length and mutations located within RGYW/WRCY hotspot motifs (D).</s><s>Data from 65 tetanus toxoid (TT)-specific PB<ref type="bibr" target="#b17">18</ref> from blood 1 week after intramuscular TetDiph vaccination from 3 donors, respectively, are shown for comparison.</s><s>After x 2 tests did not show significant differences in V H J H C segment use and CDR3 length distribution among different individuals' samples, data were pooled and displayed together.</s><s>Mann-Whitney U test was used to analyze data in (D) (*P , .05;</s><s>**P , .01;</s><s>***P , .001).</s><s>Median values are indicated.</s><s>(E) Frequencies of antibody-secreting PC specific for TT were determined by Elispot among 4 pairs of FACS-sorted CD19 1 and CD19 2 BMPC (donors were aged 37, 52, 62, and 72 years).</s><s>Median values are indicated.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s>Figure 2. CD19 2 BMPC express IgG with moderately mutated V H gene rearrangements and secrete antibodies commonly found in blood serum.</s><s>(A) BMPC were analyzed for expression of CD19 and cyt IgG, IgM, and IgA.</s><s>Summarized results from 11 donors are shown in (B) and were compared using the Mann-Whitney U test, ***P , .001.</s><s>Median values are indicated.</s><s>(C-D) Individual fluorescence-activated cell sorter (FACS)-sorted CD19 1 and CD192BMPC from 3 individuals were subjected to nested single-cell reverse transcriptase-polymerase chain reaction for amplification of V H DJ H C gene rearrangements.<ref type="bibr" target="#b17">18</ref></s><s>A total of 82 sequences from CD19 1 PC and 72 sequences from CD19 2 BMPC were analyzed: 33 CD19 1 IgG 1 , 44 CD19 2 IgG 1 , 46 CD19 1 IgA 1 , and 24 CD19 2 IgA 1 sequences (and 7 IgM sequences, not separately shown).</s><s>Sequences were analyzed for immunoglobulin isotype (supplemental Figure2B) for V H and J H family use.</s><s>Distributions were compared by x 2 test; respective P values are indicated (C), for absolute numbers and frequencies of somatic mutations per V H sequence, and for CDR3 length and mutations located within RGYW/WRCY hotspot motifs (D).</s><s>Data from 65 tetanus toxoid (TT)-specific PB<ref type="bibr" target="#b17">18</ref> from blood 1 week after intramuscular TetDiph vaccination from 3 donors, respectively, are shown for comparison.</s><s>After x 2 tests did not show significant differences in V H J H C segment use and CDR3 length distribution among different individuals' samples, data were pooled and displayed together.</s><s>Mann-Whitney U test was used to analyze data in (D) (*P , .05;</s><s>**P , .01;</s><s>***P , .001).</s><s>Median values are indicated.</s><s>(E) Frequencies of antibody-secreting PC specific for TT were determined by Elispot among 4 pairs of FACS-sorted CD19 1 and CD19 2 BMPC (donors were aged 37, 52, 62, and 72 years).</s><s>Median values are indicated.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3.</s><s>The phenotype of CD19 2 BMPC indicates terminal PC differentiation and prosurvival capacity.</s><s>(A) CD19 1 and CD19 2 BMPC were isolated from 4 donors using a combined magnetic-activated cell-sorting/FACS protocol (supplemental Figure 4) and were subjected to global gene expression profiling.</s><s>A heat map resulting from unsupervised clustering of data of 859 significantly differentially expressed probe sets reflecting 689 genes (supplemental Table IIIA) according to high-performance chip data analysis (HPCDA) after Bonferroni correction is shown.</s><s>(B) CD19 1 and CD19 2 BMPC (CD38 high CD3 2 CD14 2 DAPI 2 ) were analyzed by flow cytometry for the expression of CD28, CD56, HLA-DR, or CD95.</s><s>Histograms representative of 8 (CD28), 14 (CD56), 18 (HLA-DR), or 19 (CD95) donors are shown.</s><s>Numbers represent median values of the geometric mean fluorescence intensity values of all donors analyzed, frequencies represent median values of frequencies of PC expressing a marker gated as illustrated by the black bars in the histogram plots, where applicable (gray, CD19 2 BMPC; black CD19 1 BMPC).</s><s>Both median fluorescence intensity and frequency data were compared using the Wilcoxon test (**P , .01;</s><s>***P , .001).</s><s>(C) Affymetrix signal intensity data for selected molecules involved in apoptosis regulation not contained in the list of differentially expressed genes as delivered by HPCDA, that is, BCL2 (B-cell lymphoma 2, probeset 203685_at), TNFRSF6 (CD95), TNFRSF10B (tumor necrosis factorrelated apoptosis-inducing ligand receptor 2), BID (BH3 interacting-domain death agonist), and for caspases 8 and 3 (supplemental TableIIIB), were extracted from global gene expression analysis of CD19 1 and CD19 2 BMPC.</s><s>A distinct probeset for BCL2 (203685_at) was identified as differentially expressed by HPCDA.</s><s>Student t test P values (BCL2, 0.05; TNFRSF6, 0.01; TNFRSF10B, 0.10 ; BID, 0.002 ; CASP8, 5.3 3 10 25 ; and CASP3, 1.1 3 10 25 , were not considered significant according to the significance level of 0.05 corrected for multiple comparisons in the overall analysis (P 5 2.29 3 10 28 ).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. CD19 1 and CD19 2 BMPC subsets exhibit different ex vivo proliferation and in vivo persistence.</s><s>(A) CD19 1 and CD192 BMPC and peripheral blood PB/PC were analyzed for the expression of Ki-67 after cell fixation with formaldehyde and permeabilization with saponin.</s><s>Frequencies of Ki-67 1 cells are shown and were compared between blood PB/PC (6 samples, steady state) and BMPC subsets (Mann-Whitney U test; ***P , .001) and among pairs of BM CD19 1 and CD19 2 PC (Wilcoxon test; *P , .05).</s><s>Filled circles, Ki-67 staining (10 samples); open circles, control staining (available for 7 samples).</s><s>Both BMPC subsets show frequencies of Ki-67 1 cells significantly exceeding frequencies of isotype control stained cells (Mann-Whitney U test; both P , .01).</s><s>Median values are indicated.</s><s>(B)BM samples of 23 patients with rheumatoid arthritis treated with 2 3 1 g RTX (a chimeric anti-CD20 antibody) were analyzed for the presence of CD138 1 CD19 1 and CD138 1 CD19 2 PC twice, once before, and once again 1 to 3 months after treatment.</s><s>PC were detected by flow cytometry, and their numbers were extrapolated according to Trepel<ref type="bibr" target="#b19">20</ref> and were analyzed using the Wilcoxon test; *P , .05.</s><s>Lines between data points indicate the trend shown by individual patients.</s><s>Mean numbers of 3.10 3 10 8 (standard deviation [SD], 1.76 3 10 8 ) CD19 1 and 1.36 3 10 8 (SD, 0.85 3 10 8 ) CD19 2 BMPC compare with 2.24 3 10 8 (SD, 1.69 3 10 8 ) CD19 1 and 1.06 3 10 8 (SD, 0.93 3 10 8 ) CD19 2 BMPC after therapy, respectively.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>Figure 5. CD19 1 but not CD19 2 PB and PC are detectable in peripheral blood after vaccination.</s><s>(A) TT-specific PB, IgG 1 HLA-DR high PB and IgG 1 HLA-DR low PC were detected in peripheral blood by flow cytometry as shown (1 week after vaccination) and were analyzed for expression of CD19 in individuals before and at indicated time points after intramuscular vaccination against TetDiph.</s><s>The analysis shown is representative of 9 individuals immunized with TetDiph vaccine.</s><s>Numbers of TT-specific PB/mL blood are indicated to illustrate kinetics of the TT-specific PB response.</s><s>(B) CD19 expression by PB/PC from 4 individuals 1 week after vaccination against 2009 H1N1 influenza with Pandemrix.</s><s>(C) CD56 1 PB and PC are absent from peripheral blood before and after vaccination.</s><s>Representative analyses are shown for circulating PB/PC during steady state (#1 to #4), 1 week after TetDiph vaccination (#5 to #8) and 1 week after Pandemrix vaccination (#9 to #12).</s></p></div></figDesc><graphic coords="7,241.91,80.01,244.22,423.14" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="8,66.95,82.17,308.66,348.98" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s><ref type="bibr" target="#b1">2</ref></s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc><div><p><s><ref type="bibr" target="#b1">2</ref></s></p></div></figDesc><table /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Downloaded from http://ashpublications.org/blood/article-pdf/125/11/1739/1383596/1739.pdf by guest on 17 May 2022</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The authors thank Toralf Kaiser, Katharina Raba, and Jenny Kirsch for assistance with cell sorting, and Karin Reiter, Simone Spieckermann, and the German Rheumatism Research Center Berlin Central Laboratory for excellent technical assistance.</s><s>The authors thank Karin Schwarz, Kathi Thiele, and the BCRT Cell Harvesting Laboratory for the provision of samples, and the authors thank Heidi Schliemann and Andreas Gr ützkau from the Reginevon-Ramin-Laboratory for Molecular Rheumatology, who were responsible for processing global gene expression arrays.</s></p><p><s>This work was supported by German Research Foundation grants Do 491/8-1/2 (SPP Immunobone), Do491/7-3, SFB633/TP A14, SFB650/TP12, Mu844/13-1, the DGRh start-up grant, and by the Berlin Senate through Charité University Medicine.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authorship</head><p><s>Contribution: H.E.M., I.W., D.F., C.G., M.B., J.R.G., T.A., S.S., K.L., A.A.K., R.E., and T.S. performed experiments and analyzed results; H.E.M., I.W., and A.A.K. created the figures; H.E.M. and T.D. planned research and experimental strategy; H.E.M. wrote the manuscript; T.D., A.R., I.W., K.L., C.G., D.F., and J.R.G. evaluated the data, edited the manuscript, and provided advice; and T.A., R.E., T.S., M.D., M.B., and C.P. provided vital material or data for the study and discussed results.</s></p><p><s>Conflict-of-interest disclosure: The authors declare no competing financial interests.</s></p><p><s>The current affiliation for H.E.M. is the Human Immune Monitoring Center, Institute for Immunity, Transplantation and Infection, Stanford School of Medicine, Stanford University, Stanford, CA.</s></p><p><s>The current affiliation for K.L. is Mucosal Immunology, Department of Experimental Medical Science, Lund University, Lund, Sweden.</s></p><p><s>Correspondence: Henrik Mei, The Human Immune Monitoring Center (HIMC), Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, 299 Campus Dr, Fairchild Science Building, Room D033, Stanford, CA 94305; e-mail: hemei@stanford.edu</s><s>or mei@drfz.de.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Survival of long-lived plasma cells is independent of antigen</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Manz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cassese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Thiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Radbruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1703" to="1711" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Lifetime of plasma cells in the bone marrow</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Manz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Radbruch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="issue">6638</biblScope>
			<biblScope unit="page" from="133" to="134" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Competence and competition: the challenge of becoming a long-lived plasma cell</title>
		<author>
			<persName><forename type="first">A</forename><surname>Radbruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Muehlinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Luger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="741" to="750" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Bcl-21 tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts</title>
		<author>
			<persName><forename type="first">P</forename><surname>Merville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Desmouli Ère</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="227" to="236" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Memory B and memory plasma cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">237</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="117" to="139" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Duration of humoral immunity to common viral and vaccine antigens</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Amanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Slifka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">357</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="1903" to="1915" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Role of the CD19 and CD21/35 receptor complex in innate immunity, host defense and autoimmunity</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Haas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Tedder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Exp Med Biol</title>
		<imprint>
			<biblScope unit="volume">560</biblScope>
			<biblScope unit="page" from="125" to="139" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Identification of BSAP (Pax-5) target genes in early B-cell development by lossand gain-of-function experiments</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Nutt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rolink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Busslinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2319" to="2333" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Kozmik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Busslinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2662" to="2672" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Pax5: the guardian of B cell identity and function</title>
		<author>
			<persName><forename type="first">C</forename><surname>Cobaleda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schebesta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Delogu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Busslinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="463" to="470" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Phenotypic difference of normal plasma cells from mature myeloma cells</title>
		<author>
			<persName><forename type="first">H</forename><surname>Harada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Kawano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2658" to="2663" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations</title>
		<author>
			<persName><forename type="first">S</forename><surname>Arce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Luger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Muehlinghaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Leukoc Biol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1022" to="1028" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression</title>
		<author>
			<persName><forename type="first">F</forename><surname>Medina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Segundo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Campos-Caro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gonz Ález-García</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Brieva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2154" to="2161" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Antigen-selected, immunoglobulin-secreting cells persist in human spleen and bone marrow</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Ellyard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Avery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Phan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Hare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Hodgkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Tangye</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="3805" to="3812" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Six color flow cytometry detects plasma cells expressing aberrant immunophenotype in bone marrow of healthy donors</title>
		<author>
			<persName><forename type="first">V</forename><surname>Peceliunas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Janiulioniene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Matuzeviciene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Griskevicius</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytometry B Clin Cytom</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="318" to="323" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pellat-Deceunynck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bataille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Robillard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2597" to="2603" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Blood-borne human plasma cells in steady state are derived from mucosal immune responses</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Mei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Sime</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2461" to="2469" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Secondary immunization generates clonally related antigenspecific plasma cells and memory B cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Fr Ölich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Giesecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Mei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="3103" to="3110" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Steady-state generation of mucosal IgA1 plasmablasts is not abrogated by B-cell depletion therapy with rituximab</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Mei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fr Ölich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Giesecke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="5181" to="5190" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Number and distribution of lymphocytes in man. A critical analysis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Trepel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Klin Wochenschr</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="511" to="515" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Immunoglobulin synthesis by human lymphoid tissues: normal bone marrow as a major site of IgG production</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mcmillan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Longmire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Yelenosky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Heath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Craddock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1386" to="1394" />
			<date type="published" when="1972">1972</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Benner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hijmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Haaijman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response</title>
		<author>
			<persName><forename type="first">M</forename><surname>Odendahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Hoyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1614" to="1621" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Regulatory role of CD95 ligation on human B cells induced in vivo capable of spontaneous and highrate Ig secretion</title>
		<author>
			<persName><forename type="first">F</forename><surname>Medina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Segundo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rodríguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Brieva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="700" to="706" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">The endoplasmic reticulum is a key component of the plasma cell death pathway</title>
		<author>
			<persName><forename type="first">N</forename><surname>Pelletier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Casamayor-Pallejà</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Luca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1340" to="1347" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">TRAIL/Apo-2 ligand induces primary plasma cell apoptosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ursini-Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Altmeyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="5505" to="5513" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Strasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Whittingham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Vaux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="8661" to="8665" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Mcl-1 is essential for the survival of plasma cells</title>
		<author>
			<persName><forename type="first">V</forename><surname>Peperzak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Vikstr Öm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Walker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="290" to="297" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Short-and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rehnberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Amu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Bokarewa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brisslert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Res Ther</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">R123</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Zand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huggins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transplantation</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1507" to="1515" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition</title>
		<author>
			<persName><forename type="first">S</forename><surname>Meister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Neubert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1783" to="1792" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Hauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Debes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Arce</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1277" to="1282" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals</title>
		<author>
			<persName><forename type="first">G</forename><surname>Cassese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Arce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Hauser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1684" to="1690" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Duration of antiviral immunity after smallpox vaccination</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hammarlund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Hansen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1131" to="1137" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Longlived plasma cells and their contribution to autoimmunity</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Hoyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Manz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Radbruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hiepe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1050</biblScope>
			<biblScope unit="page" from="124" to="133" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Inflamed kidneys of NZB / W mice are a major site for the homeostasis of plasma cells</title>
		<author>
			<persName><forename type="first">G</forename><surname>Cassese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lindenau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>De Boer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2726" to="2732" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Plasma cell ontogeny defined by quantitative changes in blimp-1 expression</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kallies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hasbold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Tarlinton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">200</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="967" to="977" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Tp44 molecules involved in antigenindependent T cell activation are expressed on human plasma cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kozbor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moretta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Messner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Moretta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Croce</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="4128" to="4132" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Delogu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schebesta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Aschenbrenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Perlot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Busslinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="269" to="281" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">CD28-B7 interaction modulates short-and long-lived plasma cell function</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Njau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Chappell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2758" to="2767" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Rozanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Arens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Carlson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">208</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1435" to="1446" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">The CD28/B7 pathway: a novel regulator of plasma cell function</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Njau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jacob</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Exp Med Biol</title>
		<imprint>
			<biblScope unit="volume">785</biblScope>
			<biblScope unit="page" from="67" to="75" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Koorella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1243" to="1253" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Minges Wols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Underhill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Kansas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Witte</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="4213" to="4221" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Static and dynamic components synergize to form a stable survival niche for bone marrow plasma cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zehentmeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Cseresnyes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2306" to="2317" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Basophils support the survival of plasma cells in mice</title>
		<author>
			<persName><forename type="first">Rodriguez</forename><surname>Gomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Talke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Goebel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Reich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="7180" to="7185" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Eosinophils are required for the maintenance of plasma cells in the bone marrow</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">T</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fr Öhlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Steinhauser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="151" to="159" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow</title>
		<author>
			<persName><forename type="first">O</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Moser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mohr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1867" to="1875" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Ely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Knowles</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1293" to="1299" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin</title>
		<author>
			<persName><forename type="first">S</forename><surname>Barill É</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Collette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bataille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Amiot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="3151" to="3159" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<monogr>
		<title level="m" type="main">Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Battula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Treml</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bareiss</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="173" to="184" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Comparative characteristics of mesenchymal stem cells from human bone marrow and placenta: CD10, CD49d, and CD56 make a difference</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mariotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mirabelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Abate</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stem Cells Dev</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1039" to="1041" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rawstron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Barrans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Blythe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="138" to="143" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Prognostic relevance of CD56 expression in multiple myeloma: a study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant</title>
		<author>
			<persName><forename type="first">H</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Samiee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">L</forename><surname>Yi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leuk Lymphoma</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="43" to="47" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rafei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hsieh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fortier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="4991" to="4998" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Maintenance of the plasma cell pool is independent of memory B cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ahuja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Khalil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Shlomchik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="4802" to="4807" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Teng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Levarht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hashemi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3909" to="3918" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Cambridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Leandro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Edwards</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2146" to="2154" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE</title>
		<author>
			<persName><forename type="first">T</forename><surname>Vallerskog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gunnarsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Widhe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="62" to="74" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Somatic diversification in the absence of antigendriven responses is the hallmark of the IgM1 IgD1 CD271 B cell repertoire in infants</title>
		<author>
			<persName><forename type="first">S</forename><surname>Weller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mamani-Matsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Picard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">205</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1331" to="1342" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Variable region gene analysis of B cell subsets derived from a 4-year-old child: somatically mutated memory B cells accumulate in the peripheral blood already at young age</title>
		<author>
			<persName><forename type="first">U</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rajewsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1383" to="1393" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wrammert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Koutsonanos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">208</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="181" to="193" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Differential regulation of self-reactivity discriminates between IgG1 human circulating memory B cells and bone marrow plasma cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Scheid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mouquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yurasov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Nussenzweig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wardemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">44</biblScope>
			<biblScope unit="page" from="18044" to="18048" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">High affinity germinal center B cells are actively selected into the plasma cell compartment</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Phan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Paus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">203</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2419" to="2424" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Zand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pellegrin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2895" to="2903" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Neubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Meister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Moser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="748" to="755" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">CD19: a promising B cell target for rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Tedder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Rheumatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="572" to="577" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Mei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Res Ther</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">S1</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19)</title>
		<author>
			<persName><forename type="first">B</forename><surname>Van Camp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Durie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="377" to="382" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">CD200 is a new prognostic factor in multiple myeloma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Moreaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Reme</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="4194" to="4197" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma</title>
		<author>
			<persName><forename type="first">D</forename><surname>Alapat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Coviello-Malle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Owens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Pathol</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="93" to="100" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
